CDK1 and malignant colon neoplasm: Additionally, because phosphorylation of cyclin B1 is important for cyclin-B1/cdc2 kinase activation [32], we suggest that treatment of MB-653 triggers a dose-dependent accumulation of G2/M phase colon cancer cells through the dysfunction of the cyclin B1/CDC2 complex.